Eli Lilly is suing six companies for allegedly selling illegal retatrutide products. Retatrutide is a new glucagon-like ...

Phase 3 TRIUMPH readouts show dose-dependent mean weight loss up to ~30% at 104 weeks in obesity and ~21% in T2D, with triglyceride, non-HDL, and SBP benefits. Market hype reflects analyst models of ...

When it comes to weight loss, moving the scale can feel daunting. You're trying to figure out the best diet plan, exercise routine and how to maintain positive mental health through it all. It can ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with obesity lost 25% of their body weight at 80 ...

Spread the love“`html There’s a buzz in the medical community and among the general public that you can almost taste. It’s ...

Eli Lilly and Co LLY is intensifying its battle against the illegal distribution of its investigational drug, retatrutide.

A Pennington Biomedical researcher explains unexpected GLP-1 benefits, potential risks, muscle loss, alcohol cravings and ...

In a recent update on Eli Lilly’s Phase 3 clinical studies investigating retatrutide—a GIP, GLP-1, and glucagon triple-hormone receptor agonist—the company reported that long-term use achieved ...

He takes vials from his refrigerator of GHK-Cu, which he said will give him "beautiful skin" and Retatrutide, which will help him "feel less hungry." ...

Test results on an unapproved peptide have revealed double the concentration listed on the label, prompting warnings from health professionals about "enormous" overdose risks. The vial of black-market ...

When it comes to weight loss, moving the scale can feel daunting. You're trying to figure out the best diet plan, exercise routine and how to maintain positive mental health through it all. It can ...